Selected research
Market Structure
Global Seasonal Influenza Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Seasonal Influenza Vaccines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Seasonal Influenza Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Seasonal Influenza Vaccines include Changsheng Bio-Technology, Sanofi, Novartis International AG, Merck & Co., Inc., Pfizer Inc, GlaxoSmithKline plc, AstraZeneca, Viatris Inc. and Vaxess Technologies Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Seasonal Influenza Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Seasonal Influenza Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Seasonal Influenza Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Seasonal Influenza Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.
Seasonal Influenza Vaccines Segment by Company
Changsheng Bio-Technology
Sanofi
Novartis International AG
Merck & Co., Inc.
Pfizer Inc
GlaxoSmithKline plc
AstraZeneca
Viatris Inc.
Vaxess Technologies Inc
Sinovac Biotech Ltd
SINOVAC
OSIVAX
Jiangsu Simcere Vaxtec Bio-pharmaceutical
EMERGEX VACCINES
EMERGENT
Dalian Hissen Bio-pharm
CSL Limited
Ccbio SA
Aleph Biomedical
Abbott Laboratories
Seasonal Influenza Vaccines Segment by Type
Type B
Type A (H3N2)
Type A (H1N1)
Seasonal Influenza Vaccines Segment by Application
Adults
Pediatrics
Elderly
Adolescence
Seasonal Influenza Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Seasonal Influenza Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Seasonal Influenza Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Seasonal Influenza Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Seasonal Influenza Vaccines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Seasonal Influenza Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Seasonal Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Seasonal Influenza Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
List of Tables
Table 1. Seasonal Influenza Vaccines Industry Trends
Table 2. Seasonal Influenza Vaccines Industry Drivers
Table 3. Seasonal Influenza Vaccines Industry Opportunities and Challenges
Table 4. Seasonal Influenza Vaccines Industry Restraints
Table 5. Global Seasonal Influenza Vaccines Revenue by Manufacturers (US$ Million) & (2021-2026)
Table 6. Global Seasonal Influenza Vaccines Revenue Market Share by Manufacturers (2021-2026)
Table 7. Global Seasonal Influenza Vaccines Sales by Manufacturers (W Units) & (2021-2026)
Table 8. Global Seasonal Influenza Vaccines Sales Market Share by Manufacturers
Table 9. Global Seasonal Influenza Vaccines Average Sales Price (US$/Unit) of Manufacturers (2021-2026)
Table 10. Global Seasonal Influenza Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
Table 11. Global Seasonal Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters
Table 12. Global Seasonal Influenza Vaccines Manufacturers, Product Type & Application
Table 13. Global Seasonal Influenza Vaccines Manufacturers Establishment Date
Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Global Seasonal Influenza Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025)
Table 16. Major Manufacturers of Type B
Table 17. Major Manufacturers of Type A (H3N2)
Table 18. Major Manufacturers of Type A (H1N1)
Table 19. Global Seasonal Influenza Vaccines Sales by Type 2021 VS 2025 VS 2032 (W Units)
Table 20. Global Seasonal Influenza Vaccines Sales by Type (2021-2026) & (W Units)
Table 21. Global Seasonal Influenza Vaccines Sales by Type (2027-2032) & (W Units)
Table 22. Global Seasonal Influenza Vaccines Sales Market Share by Type (2021-2026)
Table 23. Global Seasonal Influenza Vaccines Sales Market Share by Type (2027-2032)
Table 24. Global Seasonal Influenza Vaccines Revenue by Type 2021 VS 2025 VS 2032 (W Units)
Table 25. Global Seasonal Influenza Vaccines Revenue by Type (2021-2026) & (W Units)
Table 26. Global Seasonal Influenza Vaccines Revenue by Type (2027-2032) & (W Units)
Table 27. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2021-2026)
Table 28. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2027-2032)
Table 29. Major Manufacturers of Adults
Table 30. Major Manufacturers of Pediatrics
Table 31. Major Manufacturers of Elderly
Table 32. Major Manufacturers of Adolescence
Table 33. Global Seasonal Influenza Vaccines Sales by Application 2021 VS 2025 VS 2032 (W Units)
Table 34. Global Seasonal Influenza Vaccines Sales by Application (2021-2026) & (W Units)
Table 35. Global Seasonal Influenza Vaccines Sales by Application (2027-2032) & (W Units)
Table 36. Global Seasonal Influenza Vaccines Sales Market Share by Application (2021-2026)
Table 37. Global Seasonal Influenza Vaccines Sales Market Share by Application (2027-2032)
Table 38. Global Seasonal Influenza Vaccines Revenue by Application 2021 VS 2025 VS 2032 (W Units)
Table 39. Global Seasonal Influenza Vaccines Revenue by Application (2021-2026) & (W Units)
Table 40. Global Seasonal Influenza Vaccines Revenue by Application (2027-2032) & (W Units)
Table 41. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2021-2026)
Table 42. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2027-2032)
Table 43. Global Seasonal Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032 (W Units)
Table 44. Global Seasonal Influenza Vaccines Sales by Region (2021-2026) & (W Units)
Table 45. Global Seasonal Influenza Vaccines Sales Market Share by Region (2021-2026)
Table 46. Global Seasonal Influenza Vaccines Sales Forecasted by Region (2027-2032) & (W Units)
Table 47. Global Seasonal Influenza Vaccines Sales Forecasted Market Share by Region (2027-2032)
Table 48. North America Seasonal Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units)
Table 49. North America Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units)
Table 50. North America Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units)
Table 51. Europe Seasonal Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units)
Table 52. Europe Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units)
Table 53. Europe Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units)
Table 54. Asia Pacific Seasonal Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units)
Table 55. Asia Pacific Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units)
Table 56. Asia Pacific Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units)
Table 57. South America, Middle East and Africa Seasonal Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units)
Table 58. South America, Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2021-2026) & (W Units)
Table 59. South America, Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2027-2032) & (W Units)
Table 60. Global Seasonal Influenza Vaccines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Table 61. Global Seasonal Influenza Vaccines Revenue by Region (2021-2026) & (US$ Million)
Table 62. Global Seasonal Influenza Vaccines Revenue by Region (2027-2032) & (US$ Million)
Table 63. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2021-2026)
Table 64. Global Seasonal Influenza Vaccines Revenue Market Share by Region (2027-2032)
Table 65. Changsheng Bio-Technology Company Information
Table 66. Changsheng Bio-Technology Business Overview
Table 67. Changsheng Bio-Technology Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 68. Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
Table 69. Changsheng Bio-Technology Recent Development
Table 70. Sanofi Company Information
Table 71. Sanofi Business Overview
Table 72. Sanofi Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 73. Sanofi Seasonal Influenza Vaccines Product Portfolio
Table 74. Sanofi Recent Development
Table 75. Novartis International AG Company Information
Table 76. Novartis International AG Business Overview
Table 77. Novartis International AG Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 78. Novartis International AG Seasonal Influenza Vaccines Product Portfolio
Table 79. Novartis International AG Recent Development
Table 80. Merck & Co., Inc. Company Information
Table 81. Merck & Co., Inc. Business Overview
Table 82. Merck & Co., Inc. Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 83. Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
Table 84. Merck & Co., Inc. Recent Development
Table 85. Pfizer Inc Company Information
Table 86. Pfizer Inc Business Overview
Table 87. Pfizer Inc Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 88. Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
Table 89. Pfizer Inc Recent Development
Table 90. GlaxoSmithKline plc Company Information
Table 91. GlaxoSmithKline plc Business Overview
Table 92. GlaxoSmithKline plc Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 93. GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
Table 94. GlaxoSmithKline plc Recent Development
Table 95. AstraZeneca Company Information
Table 96. AstraZeneca Business Overview
Table 97. AstraZeneca Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 98. AstraZeneca Seasonal Influenza Vaccines Product Portfolio
Table 99. AstraZeneca Recent Development
Table 100. Viatris Inc. Company Information
Table 101. Viatris Inc. Business Overview
Table 102. Viatris Inc. Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 103. Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
Table 104. Viatris Inc. Recent Development
Table 105. Vaxess Technologies Inc Company Information
Table 106. Vaxess Technologies Inc Business Overview
Table 107. Vaxess Technologies Inc Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 108. Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
Table 109. Vaxess Technologies Inc Recent Development
Table 110. Sinovac Biotech Ltd Company Information
Table 111. Sinovac Biotech Ltd Business Overview
Table 112. Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 113. Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
Table 114. Sinovac Biotech Ltd Recent Development
Table 115. SINOVAC Company Information
Table 116. SINOVAC Business Overview
Table 117. SINOVAC Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 118. SINOVAC Seasonal Influenza Vaccines Product Portfolio
Table 119. SINOVAC Recent Development
Table 120. OSIVAX Company Information
Table 121. OSIVAX Business Overview
Table 122. OSIVAX Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 123. OSIVAX Seasonal Influenza Vaccines Product Portfolio
Table 124. OSIVAX Recent Development
Table 125. Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
Table 126. Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview
Table 127. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 128. Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
Table 129. Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Development
Table 130. EMERGEX VACCINES Company Information
Table 131. EMERGEX VACCINES Business Overview
Table 132. EMERGEX VACCINES Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 133. EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
Table 134. EMERGEX VACCINES Recent Development
Table 135. EMERGENT Company Information
Table 136. EMERGENT Business Overview
Table 137. EMERGENT Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 138. EMERGENT Seasonal Influenza Vaccines Product Portfolio
Table 139. EMERGENT Recent Development
Table 140. Dalian Hissen Bio-pharm Company Information
Table 141. Dalian Hissen Bio-pharm Business Overview
Table 142. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 143. Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
Table 144. Dalian Hissen Bio-pharm Recent Development
Table 145. CSL Limited Company Information
Table 146. CSL Limited Business Overview
Table 147. CSL Limited Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 148. CSL Limited Seasonal Influenza Vaccines Product Portfolio
Table 149. CSL Limited Recent Development
Table 150. Ccbio SA Company Information
Table 151. Ccbio SA Business Overview
Table 152. Ccbio SA Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 153. Ccbio SA Seasonal Influenza Vaccines Product Portfolio
Table 154. Ccbio SA Recent Development
Table 155. Aleph Biomedical Company Information
Table 156. Aleph Biomedical Business Overview
Table 157. Aleph Biomedical Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 158. Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
Table 159. Aleph Biomedical Recent Development
Table 160. Abbott Laboratories Company Information
Table 161. Abbott Laboratories Business Overview
Table 162. Abbott Laboratories Seasonal Influenza Vaccines Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026)
Table 163. Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
Table 164. Abbott Laboratories Recent Development
Table 165. Key Raw Materials
Table 166. Raw Materials Key Suppliers
Table 167. Seasonal Influenza Vaccines Distributors List
Table 168. Seasonal Influenza Vaccines Customers List
Table 169. Research Programs/Design for This Report
Table 170. Authors List of This Report
Table 171. Secondary Sources
Table 172. Primary Sources
List of Figures
Figure 1. Seasonal Influenza Vaccines Product Image
Figure 2. Global Seasonal Influenza Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032
Figure 3. Global Seasonal Influenza Vaccines Market Size (2021-2032) & (US$ Million)
Figure 4. Global Seasonal Influenza Vaccines Sales (2021-2032) & (W Units)
Figure 5. Global Seasonal Influenza Vaccines Average Price (US$/Unit) & (2021-2032)
Figure 6. Global Top 5 and 10 Seasonal Influenza Vaccines Players Market Share by Revenue in 2025
Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 8. Type B Image
Figure 9. Type A (H3N2) Image
Figure 10. Type A (H1N1) Image
Figure 11. Global Seasonal Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032) & (W Units)
Figure 12. Global Seasonal Influenza Vaccines Sales Market Share 2021 VS 2025 VS 2032
Figure 13. Global Seasonal Influenza Vaccines Sales Market Share by Type (2021-2032)
Figure 14. Global Seasonal Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032) & (W Units)
Figure 15. Global Seasonal Influenza Vaccines Revenue Market Share 2021 VS 2025 VS 2032
Figure 16. Global Seasonal Influenza Vaccines Revenue Market Share by Type (2021-2032)
Figure 17. Adults Image
Figure 18. Pediatrics Image
Figure 19. Elderly Image
Figure 20. Adolescence Image
Figure 21. Global Seasonal Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032) & (W Units)
Figure 22. Global Seasonal Influenza Vaccines Sales Market Share 2021 VS 2025 VS 2032
Figure 23. Global Seasonal Influenza Vaccines Sales Market Share by Application (2021-2032)
Figure 24. Global Seasonal Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032) & (W Units)
Figure 25. Global Seasonal Influenza Vaccines Revenue Market Share 2021 VS 2025 VS 2032
Figure 26. Global Seasonal Influenza Vaccines Revenue Market Share by Application (2021-2032)
Figure 27. North America Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 28. North America Seasonal Influenza Vaccines Sales Market Share by Country (2021-2032)
Figure 29. U.S. Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 30. Canada Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 31. Mexico Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 32. Europe Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 33. Europe Seasonal Influenza Vaccines Sales Market Share by Country (2021-2032)
Figure 34. Germany Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 35. France Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 36. U.K. Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 37. Italy Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 38. Netherlands Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 39. Asia Pacific Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 40. Asia Pacific Seasonal Influenza Vaccines Sales Market Share by Country (2021-2032)
Figure 41. China Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 42. Japan Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 43. South Korea Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 44. Southeast Asia Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 45. India Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 46. Australia Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 47. South America, Middle East and Africa Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 48. South America, Middle East and Africa Seasonal Influenza Vaccines Sales Market Share by Country (2021-2032)
Figure 49. Brazil Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 50. South Africa Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 51. Saudi Arabia Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 52. Turkey Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 53. Argentina Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 54. UAE Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 55. Egypt Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 56. Chile Seasonal Influenza Vaccines Sales and Growth Rate (2021-2032) & (W Units)
Figure 57. Global Seasonal Influenza Vaccines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million)
Figure 58. Global Seasonal Influenza Vaccines Revenue Market Share by Region in Percentage: 2025 Versus 2032
Figure 59. North America Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million)
Figure 60. North America Seasonal Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 61. Europe Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million)
Figure 62. Europe Seasonal Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 63. Asia-Pacific Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million)
Figure 64. Asia-Pacific Seasonal Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 65. South America, Middle East and Africa Seasonal Influenza Vaccines Revenue (2021-2032) & (US$ Million)
Figure 66. South America, Middle East and Africa Seasonal Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
Figure 67. Seasonal Influenza Vaccines Value Chain
Figure 68. Manufacturing Cost Structure
Figure 69. Seasonal Influenza Vaccines Production Mode & Process
Figure 70. Direct Comparison with Distribution Share
Figure 71. Distributors Profiles
Figure 72. Years Considered
Figure 73. Research Process
Figure 74. Key Executives Interviewed
Scope & coverage.
Types
- Type B
- Type A (H3N2)
- Type A (H1N1)
Applications
- Adults
- Pediatrics
- Elderly
- Adolescence
Companies covered
- Changsheng Bio-Technology
- Sanofi
- Novartis International AG
- Merck & Co., Inc.
- Pfizer Inc
- GlaxoSmithKline plc
- AstraZeneca
- Viatris Inc.
- Vaxess Technologies Inc
- Sinovac Biotech Ltd
- SINOVAC
- OSIVAX
- Jiangsu Simcere Vaxtec Bio-pharmaceutical
- EMERGEX VACCINES
- EMERGENT
- Dalian Hissen Bio-pharm
- CSL Limited
- Ccbio SA
- Aleph Biomedical
- Abbott Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Seasonal Influenza Vaccines Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Seasonal Influenza Vaccines Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Seasonal Influenza Vaccines Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Seasonal Influenza Vaccines Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Seasonal Influenza Vaccines Market Dynamics
- 2.1 Seasonal Influenza Vaccines Industry Trends
- 2.2 Seasonal Influenza Vaccines Industry Drivers
- 2.3 Seasonal Influenza Vaccines Industry Opportunities and Challenges
- 2.4 Seasonal Influenza Vaccines Industry Restraints
3 Seasonal Influenza Vaccines Market by Manufacturers
- 3.1 Global Seasonal Influenza Vaccines Revenue by Manufacturers (2021-2026)
- 3.2 Global Seasonal Influenza Vaccines Sales by Manufacturers (2021-2026)
- 3.3 Global Seasonal Influenza Vaccines Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Seasonal Influenza Vaccines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Seasonal Influenza Vaccines Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Seasonal Influenza Vaccines Manufacturers, Product Type & Application
- 3.7 Global Seasonal Influenza Vaccines Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Seasonal Influenza Vaccines Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Seasonal Influenza Vaccines Players Market Share by Revenue in 2025
- 3.8.3 2025 Seasonal Influenza Vaccines Tier 1, Tier 2, and Tier 3
4 Seasonal Influenza Vaccines Market by Type
- 4.1 Seasonal Influenza Vaccines Type Introduction
- 4.1.1 Type B
- 4.1.2 Type A (H3N2)
- 4.1.3 Type A (H1N1)
- 4.2 Global Seasonal Influenza Vaccines Sales by Type
- 4.2.1 Global Seasonal Influenza Vaccines Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Seasonal Influenza Vaccines Sales by Type (2021-2032)
- 4.2.3 Global Seasonal Influenza Vaccines Sales Market Share by Type (2021-2032)
- 4.3 Global Seasonal Influenza Vaccines Revenue by Type
- 4.3.1 Global Seasonal Influenza Vaccines Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Seasonal Influenza Vaccines Revenue by Type (2021-2032)
- 4.3.3 Global Seasonal Influenza Vaccines Revenue Market Share by Type (2021-2032)
5 Seasonal Influenza Vaccines Market by Application
- 5.1 Seasonal Influenza Vaccines Application Introduction
- 5.1.1 Adults
- 5.1.2 Pediatrics
- 5.1.3 Elderly
- 5.1.4 Adolescence
- 5.2 Global Seasonal Influenza Vaccines Sales by Application
- 5.2.1 Global Seasonal Influenza Vaccines Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Seasonal Influenza Vaccines Sales by Application (2021-2032)
- 5.2.3 Global Seasonal Influenza Vaccines Sales Market Share by Application (2021-2032)
- 5.3 Global Seasonal Influenza Vaccines Revenue by Application
- 5.3.1 Global Seasonal Influenza Vaccines Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Seasonal Influenza Vaccines Revenue by Application (2021-2032)
- 5.3.3 Global Seasonal Influenza Vaccines Revenue Market Share by Application (2021-2032)
6 Global Seasonal Influenza Vaccines Sales by Region
- 6.1 Global Seasonal Influenza Vaccines Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Seasonal Influenza Vaccines Sales by Region (2021-2032)
- 6.2.1 Global Seasonal Influenza Vaccines Sales by Region (2021-2026)
- 6.2.2 Global Seasonal Influenza Vaccines Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Seasonal Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Seasonal Influenza Vaccines Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Seasonal Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Seasonal Influenza Vaccines Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Seasonal Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Seasonal Influenza Vaccines Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Seasonal Influenza Vaccines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Seasonal Influenza Vaccines Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Seasonal Influenza Vaccines Revenue by Region
- 7.1 Global Seasonal Influenza Vaccines Revenue by Region
- 7.1.1 Global Seasonal Influenza Vaccines Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Seasonal Influenza Vaccines Revenue by Region (2021-2026)
- 7.1.3 Global Seasonal Influenza Vaccines Revenue by Region (2027-2032)
- 7.1.4 Global Seasonal Influenza Vaccines Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Seasonal Influenza Vaccines Revenue (2021-2032)
- 7.2.2 North America Seasonal Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Seasonal Influenza Vaccines Revenue (2021-2032)
- 7.3.2 Europe Seasonal Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Seasonal Influenza Vaccines Revenue (2021-2032)
- 7.4.2 Asia-Pacific Seasonal Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Seasonal Influenza Vaccines Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Seasonal Influenza Vaccines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Changsheng Bio-Technology
- 8.1.1 Changsheng Bio-Technology Company Information
- 8.1.2 Changsheng Bio-Technology Business Overview
- 8.1.3 Changsheng Bio-Technology Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Changsheng Bio-Technology Seasonal Influenza Vaccines Product Portfolio
- 8.1.5 Changsheng Bio-Technology Recent Developments
- 8.2 Sanofi
- 8.2.1 Sanofi Company Information
- 8.2.2 Sanofi Business Overview
- 8.2.3 Sanofi Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sanofi Seasonal Influenza Vaccines Product Portfolio
- 8.2.5 Sanofi Recent Developments
- 8.3 Novartis International AG
- 8.3.1 Novartis International AG Company Information
- 8.3.2 Novartis International AG Business Overview
- 8.3.3 Novartis International AG Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis International AG Seasonal Influenza Vaccines Product Portfolio
- 8.3.5 Novartis International AG Recent Developments
- 8.4 Merck & Co., Inc.
- 8.4.1 Merck & Co., Inc. Company Information
- 8.4.2 Merck & Co., Inc. Business Overview
- 8.4.3 Merck & Co., Inc. Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Merck & Co., Inc. Seasonal Influenza Vaccines Product Portfolio
- 8.4.5 Merck & Co., Inc. Recent Developments
- 8.5 Pfizer Inc
- 8.5.1 Pfizer Inc Company Information
- 8.5.2 Pfizer Inc Business Overview
- 8.5.3 Pfizer Inc Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Inc Seasonal Influenza Vaccines Product Portfolio
- 8.5.5 Pfizer Inc Recent Developments
- 8.6 GlaxoSmithKline plc
- 8.6.1 GlaxoSmithKline plc Company Information
- 8.6.2 GlaxoSmithKline plc Business Overview
- 8.6.3 GlaxoSmithKline plc Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GlaxoSmithKline plc Seasonal Influenza Vaccines Product Portfolio
- 8.6.5 GlaxoSmithKline plc Recent Developments
- 8.7 AstraZeneca
- 8.7.1 AstraZeneca Company Information
- 8.7.2 AstraZeneca Business Overview
- 8.7.3 AstraZeneca Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 AstraZeneca Seasonal Influenza Vaccines Product Portfolio
- 8.7.5 AstraZeneca Recent Developments
- 8.8 Viatris Inc.
- 8.8.1 Viatris Inc. Company Information
- 8.8.2 Viatris Inc. Business Overview
- 8.8.3 Viatris Inc. Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Viatris Inc. Seasonal Influenza Vaccines Product Portfolio
- 8.8.5 Viatris Inc. Recent Developments
- 8.9 Vaxess Technologies Inc
- 8.9.1 Vaxess Technologies Inc Company Information
- 8.9.2 Vaxess Technologies Inc Business Overview
- 8.9.3 Vaxess Technologies Inc Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Vaxess Technologies Inc Seasonal Influenza Vaccines Product Portfolio
- 8.9.5 Vaxess Technologies Inc Recent Developments
- 8.10 Sinovac Biotech Ltd
- 8.10.1 Sinovac Biotech Ltd Company Information
- 8.10.2 Sinovac Biotech Ltd Business Overview
- 8.10.3 Sinovac Biotech Ltd Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Sinovac Biotech Ltd Seasonal Influenza Vaccines Product Portfolio
- 8.10.5 Sinovac Biotech Ltd Recent Developments
- 8.11 SINOVAC
- 8.11.1 SINOVAC Company Information
- 8.11.2 SINOVAC Business Overview
- 8.11.3 SINOVAC Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 SINOVAC Seasonal Influenza Vaccines Product Portfolio
- 8.11.5 SINOVAC Recent Developments
- 8.12 OSIVAX
- 8.12.1 OSIVAX Company Information
- 8.12.2 OSIVAX Business Overview
- 8.12.3 OSIVAX Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 OSIVAX Seasonal Influenza Vaccines Product Portfolio
- 8.12.5 OSIVAX Recent Developments
- 8.13 Jiangsu Simcere Vaxtec Bio-pharmaceutical
- 8.13.1 Jiangsu Simcere Vaxtec Bio-pharmaceutical Company Information
- 8.13.2 Jiangsu Simcere Vaxtec Bio-pharmaceutical Business Overview
- 8.13.3 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Jiangsu Simcere Vaxtec Bio-pharmaceutical Seasonal Influenza Vaccines Product Portfolio
- 8.13.5 Jiangsu Simcere Vaxtec Bio-pharmaceutical Recent Developments
- 8.14 EMERGEX VACCINES
- 8.14.1 EMERGEX VACCINES Company Information
- 8.14.2 EMERGEX VACCINES Business Overview
- 8.14.3 EMERGEX VACCINES Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 EMERGEX VACCINES Seasonal Influenza Vaccines Product Portfolio
- 8.14.5 EMERGEX VACCINES Recent Developments
- 8.15 EMERGENT
- 8.15.1 EMERGENT Company Information
- 8.15.2 EMERGENT Business Overview
- 8.15.3 EMERGENT Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 EMERGENT Seasonal Influenza Vaccines Product Portfolio
- 8.15.5 EMERGENT Recent Developments
- 8.16 Dalian Hissen Bio-pharm
- 8.16.1 Dalian Hissen Bio-pharm Company Information
- 8.16.2 Dalian Hissen Bio-pharm Business Overview
- 8.16.3 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Dalian Hissen Bio-pharm Seasonal Influenza Vaccines Product Portfolio
- 8.16.5 Dalian Hissen Bio-pharm Recent Developments
- 8.17 CSL Limited
- 8.17.1 CSL Limited Company Information
- 8.17.2 CSL Limited Business Overview
- 8.17.3 CSL Limited Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 CSL Limited Seasonal Influenza Vaccines Product Portfolio
- 8.17.5 CSL Limited Recent Developments
- 8.18 Ccbio SA
- 8.18.1 Ccbio SA Company Information
- 8.18.2 Ccbio SA Business Overview
- 8.18.3 Ccbio SA Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Ccbio SA Seasonal Influenza Vaccines Product Portfolio
- 8.18.5 Ccbio SA Recent Developments
- 8.19 Aleph Biomedical
- 8.19.1 Aleph Biomedical Company Information
- 8.19.2 Aleph Biomedical Business Overview
- 8.19.3 Aleph Biomedical Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Aleph Biomedical Seasonal Influenza Vaccines Product Portfolio
- 8.19.5 Aleph Biomedical Recent Developments
- 8.20 Abbott Laboratories
- 8.20.1 Abbott Laboratories Company Information
- 8.20.2 Abbott Laboratories Business Overview
- 8.20.3 Abbott Laboratories Seasonal Influenza Vaccines Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Abbott Laboratories Seasonal Influenza Vaccines Product Portfolio
- 8.20.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Seasonal Influenza Vaccines Value Chain Analysis
- 9.1.1 Seasonal Influenza Vaccines Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Seasonal Influenza Vaccines Production Mode & Process
- 9.2 Seasonal Influenza Vaccines Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Seasonal Influenza Vaccines Distributors
- 9.2.3 Seasonal Influenza Vaccines Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$3,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst